Supernus Pharmaceuticals (SUPN) Shares Outstanding (Diluted) (2011 - 2026)
Supernus Pharmaceuticals (SUPN) Shares Outstanding (Diluted) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 833.33 Mn |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | 58.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.07 Mn |
| Mar 31, 2026 | 57.65 Mn |
| Dec 31, 2025 | 56.45 Mn |
| Sep 30, 2025 | 56.55 Mn |
| Jun 30, 2025 | 56.64 Mn |
| Mar 31, 2025 | 55.86 Mn |
| Dec 31, 2024 | 55.96 Mn |
| Sep 30, 2024 | 56.02 Mn |
| Jun 30, 2024 | 55.72 Mn |
| Mar 31, 2024 | 55.63 Mn |
| Dec 31, 2023 | 55.51 Mn |
| Sep 30, 2023 | 54.61 Mn |
| Jun 30, 2023 | 54.50 Mn |
| Mar 31, 2023 | 62.45 Mn |
| Dec 31, 2022 | 61.68 Mn |
| Sep 30, 2022 | 55.03 Mn |
| Jun 30, 2022 | 61.40 Mn |
| Mar 31, 2022 | 61.41 Mn |
| Dec 31, 2021 | 54.36 Mn |
| Sep 30, 2021 | 54.33 Mn |